about
Comparative pharmacokinetics of azlocillin and piperacillin in normal adults.Nonlinear pharmacokinetics of piperacillin in healthy volunteers--implications for optimal dosage regimensPiperacillin pharmacokinetics in subjects with chronic renal failure.Population pharmacokinetic analysis of nonlinear behavior of piperacillin during intermittent or continuous infusion in patients with cystic fibrosis.Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?Pharmacokinetics and pharmacodynamics of two multiple-dose piperacillin-tazobactam regimens.Antipseudomonal activity of simulated infusions of gentamicin alone or with piperacillin assessed by serum bactericidal rate and area under the killing curvePharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis.Piperacillin pharmacokinetics in pediatric patientsSystematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteers.Population pharmacokinetics of piperacillin at two dose levels: influence of nonlinear pharmacokinetics on the pharmacodynamic profile.Pharmacokinetics of intravenous piperacillin in patients undergoing chronic hemodialysis.Inhibition of flucloxacillin tubular renal secretion by piperacillinPharmacokinetics of intravenous piperacillin administration in patients undergoing on-line hemodiafiltration.Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulation.Augmented renal clearance: implications for antibacterial dosing in the critically ill.Piperacillin and tazobactam exhibit linear pharmacokinetics after multiple standard clinical doses.Clinical evaluation of piperacillin with observations on penetrability into cerebrospinal fluid.Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children.Piperacillin sodium: antibacterial spectrum, pharmacokinetics, clinical efficacy, and adverse reactions.Penetration of piperacillin into bronchial mucosa and sputumPharmacokinetics of piperacillin in subjects with various degrees of renal function.Comparison of the pharmacokinetics of piperacillin and sulbactam during intermittent and continuous intravenous infusion.Thermal injury effects on drug disposition: a prospective study with piperacillin.Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection.
P2860
Q33739915-BF6D8A21-74F9-4F15-BAD6-299AA06EA700Q34381321-E54F0743-A57D-43A6-856E-CDDE08712045Q34710005-636099DC-3634-4321-ABFE-D3BB4DD1D617Q34824085-DE920FEC-5F18-4127-BA14-B3922A7E938AQ35124710-5444AABC-10F4-4E9E-ADE4-C71567591D51Q35139002-2AF72DEC-9712-46B9-86B2-2193FA61799BQ35348258-6D96CEF9-55F1-476A-B330-9609106BF11EQ35668811-729A171B-27B6-4E3A-9D9B-0D6494109BF0Q35716595-28FB2937-5CFC-4B1D-9412-8CAF0337D173Q35878860-0A1612E7-5A07-40EB-A0ED-8F84A9B2078BQ36364174-1BB0338A-4E12-477B-B0C8-646B5E432C46Q36486623-4A7AC8C2-297D-44EF-AF1E-CD1A7F907C50Q37142437-22EF458F-873D-4D80-B8E7-04691ED36CD7Q37274643-F46CC9A8-4469-4F50-ADAA-AC080E55BA54Q37625193-DE24465C-53F4-43B5-B6E4-0D457C7AF5EEQ37650115-1E1702E7-E35E-43D8-81B0-7E51C38C6998Q39470971-86EC7BB4-850C-4D3D-9749-39324EC0CF92Q39855864-275A5CB0-4AD3-49E0-9583-38D698EBA0B9Q39867395-F1536989-F9CD-4215-8083-3C9E6CB63A2DQ40114428-B86D2D22-677B-42EB-A3DE-E316248A4F11Q41202241-8785A527-8346-4D2E-A48B-877ED1E4423EQ42929013-DAFD3C69-E302-4A90-8705-9A5C29859D1BQ43884648-DDEED9C5-EBDA-458A-875D-86A91800AF77Q44304095-33F467BA-8348-4209-9FF3-4123F761B100Q46588566-4D2F06DB-AA90-433E-8A4C-F8D50CEE6673
P2860
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh
1979年學術文章
@zh-hant
name
Piperacillin kinetics.
@en
type
label
Piperacillin kinetics.
@en
prefLabel
Piperacillin kinetics.
@en
P2093
P356
P1476
Piperacillin kinetics.
@en
P2093
P356
10.1002/CPT197926141
P407
P577
1979-07-01T00:00:00Z